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Background: Myofascial trigger points (MTrPs) are hyperirritable spots located in taut bands of muscle fibres.
Electrophysiological studies indicate that abnormal electrical activity is detectable near MTrPs. This phenomenon
has been described as endplate noise and it has been purported to be associated MTrP pathophysiology. Thus, it is
suggested that MTrPs will be overlap the innervation zone (IZ). The purpose of this work was to describe the
location of MTrPs and the IZ in the right upper trapezius.
Methods: We screened 71 individuals and eventually enrolled 24 subjects with neck pain and active MTrPs and
24 neck pain-free subjects with latent MTrPs. Surface electromyography (sEMG) signals were detected using an
electrode matrix during isometric contraction of the upper trapezius. A physiotherapist subsequently examined the
subject’s trapezius to confirm the presence of MTrPs and establish their location. IZ locations were identified by
visual analysis of sEMG signals. IZ and MTrPs locations were described using an anatomical coordinate system (ACS),
with the skin area covered by the matrix divided into four quadrants.
Results: No significant difference was observed between active and latent MTrPs locations (P = 0.6). Forty-five
MTrPs were in the third quadrant of the ACS, and 3 were included in second quadrant. IZs were located
approximately midway between the seventh cervical vertebrae and the acromial angle in a limited area in the
second and third quadrants. The mean distance between MTrP and IZ was 10.4 ± 5.8 mm.
Conclusions: According to the acquired results, we conclude that IZ and MTrPs are located in well-defined areas in
upper trapezius muscle. Moreover, MTrPs in upper trapezius are proximally located to the IZ but not overlapped.
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Musculoskeletal impairments are the leading cause of
work disability in middle-aged adults, and low back pain is
the most common form [1]. There are two broad clinical
categories of musculoskeletal impairments: articular and
non-articular [2]. The articular group includes joint dis-
eases (intra-articular) involving inflammation or injuries
due to trauma or degenerative processes. Typical examples
are rheumatoid arthritis or shoulder instability. The non-
articular group includes disorders that primarily affect soft
tissue (peri-articular), such as muscles, ligaments, and* Correspondence: marco.barbero@supsi.ch
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reproduction in any medium, provided the ortendons. Examples are fibromyalgia, myofascial pain syn-
drome, and tendonitis. It is thought that up to 85% of pa-
tients that visit pain clinics complain of non-articular
musculoskeletal impairments such as the myofascial pain
syndrome [3]. The first authors who systematically de-
scribed the myofascial pain syndrome were Travell and
Simons, who theorised that this painful condition is due
to the presence of myofascial trigger points (MTrPs) [4].
MTrPs are hyperirritable points located within a taut
band (TB) of skeletal muscle that cause referred pain,
local tenderness, and sometimes autonomic changes
[4,5]. An active MTrP is characherized by spontaneus
pain or pain response to movement, while a latent MTrP
is a sensitive spot with pain only elicited in response to
compression [5]. The MTrP diagnosis requires detailed
history taking and physical examination to confirm thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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teria (i.e., taut band, spot tenderness, referred pain, pain
recognition, local twitch response) [5].
MTrP pathophysiology appears to be associated with
the motor endplate zone [6-10]. This region, also known
as the innervation zone (IZ), is where the α-motor
neuron divides into a number of branches and synapses
onto target muscle fibres. The IZ is usually described as
being in the middle region of the muscle belly [11], but
more complex IZ spatial distibutions have been reported
in muscles with unipennate or multipennate fibre ar-
rangements (e.g., gastrocnemius and soleus) [12-14].
Needle electromyography (EMG) studies have demon-
strated that MTrPs contain minute loci that produce
characteristic low-amplitude electrical activity [10,15,16]
(i.e. active locus), which is described by in the literature
as spontaneous electrical activity (SEA).
The origin of SEA has been extensively debated among
experts. Initially, Hubbard and Berkoff attributed the
source of SEA action potentials to intrafusal muscle
spindles located near MTrPs [15]. Later, Simons consid-
ered previous work by Liley [17] and hypothesised that
SEA originates from motor endplates and defined it as
endplate noise [8].
In support of the last hypothesis, a needle EMG study
showed that endplate noise was more prevalent in
MTrPs than in adjacent sites [10].
This “motor endplate” hypothesis was also tested by
Kuan et al., who injected MTrPs with botulinum toxin type
A to block acetylcholine release into the synaptic cleft and
found that the injection diminished SEA in MTrPs [18].
Finally, the described electrophysiological findings
have been correlated with histological changes [19,20]
and local biochemical alterations [21,22] (e.g., inflamma-
tory mediators, neuropeptides, catecholamines, and cy-
tokines) to support MTrP pathophysiology.
The described experimental findings of MTrPs suggest
that they are located close to the IZ [2,16]. In a research
context aimed to clarify the MTrP etiology a confirm-
ation of the overlapping between MTrP and IZ will help
to clarified their interaction (i.e. the active locus and the
sensitive locus) [23]. Furthermore manual identification
of MTrPs could become useful to optimize treatments
addressed to the IZ, like botulinum injections for both
cervical dystonia and myofascial pain [24,25].
A technology useful for detecting the IZ in vivo has re-
cently proposed [26-29], and to-date, no study has
assessed both MTrP and IZ locations. Therefore, the
purpose of this work was to describe MTrP and IZ loca-
tions in the upper trapezius muscle.
Methods
All experimental sessions were conducted at the labora-
tory of movement analysis of the San Raffaele ScientificInstitute in Milan, Italy. The Internal Ethical Committee
approved the protocol. All participants signed an in-
formed consent form before enrolling in the study.
Participants
Twenty-nine patients with chronic mechanical neck pain
and 42 pain-free subjects with negative histories for
neck/shoulder pain were screened at the laboratory of
movement analysis at the San Raffaele Scientific Institute
in Milan. Patients were recruited through the Rehabilita-
tion Service of San Raffaele Hospital, and pain-free sub-
jects consisted of San Raffaele Scientific Institute
employees. Mechanical neck pain was defined as pain
elicited by active cervical spine movements and per-
ceived anywhere in the posterior region of the cervical
spine, from the superior nuchal line to the first thoracic
spinous process [30]. Neck pain subjects were screened
as they usually show MTrPs in upper and mid trapezius
muscles [4].
Patients had to meet the following inclusion criteria:
mechanical neck pain, neck pain history lasting more
than 3 months, an active or latent MTrP in the right
upper trapezius. Exclusion criteria were: positive history
for neurological or rheumatic disorders, radiculopathy,
fibromyalgia, joint disorders, whiplash in the previous
6 months, pregnancy, clinical depression and body mass
index ≥30. Concomitant painful disorders and psycho
emotional distress were ruled out to avoid adverse effects
and confounding factors during the MTrP palpation pro-
cedure. Overweight subjects were excluded because an ex-
cessive subcutaneous fat layer thickness can limit the
MTrP palpation.
Forty-eight subjects were enrolled and analysed: 18 pa-
tients with chronic neck pain and active MTrPs, 6 pa-
tients with chronic neck pain and latent MTrPs, and 24
pain-free subjects with latent MTrPs. The following sub-
jects were excluded from the study: 16 didn’t show any
MTrP in the right upper trapezius muscle, 3 were ex-
cluded due to a positive history for neurological disor-
ders, and 4 showed an MTrP located outside the area
covered by the electrode matrix.
MTrPs were detected by a physiotherapist with 10
years of clinical experience specialising in myofascial
pain syndrome diagnosis and management.
The physiotherapist explored the upper trapezius area
using a flat palpation technique [4]. Only neck pain pa-
tients with an active or latent MTrP and pain-free sub-
jects with latent MTrP were considered for further
analysis. Diagnostic criteria for active MTrP were: the
presence of a TB within the upper trapezius muscle and
at least one of the following clinical signs; the presence
of a spot tenderness (SP) within the TB, the reproduc-
tion of pain complains during mechanical stimulation of
the SP, and the reproduction of a referred pain with
Figure 1 Experimental setup. Subjects sat in a custom made chair
with a load cell connected to the right handle and were connected
to an electrode matrix (model ELSCH064, designed by LISiN at
Politecnico di Torino and manufactured by OT Bioelectronica, Torino,
Italy) placed on the upper trapezius. They viewed the visual
feedback device (MISO II, LISiN, OT Bioelettronica, Torino, Italy)
during the experiment.
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local twitch response during snapping palpation of the
TB was considered confirmatory criteria [5]. Diagnostic
criteria for latent MTrP were TB and SP.
Equipment
Surface electromyographic signals (sEMG) were detected
using a matrix (model ELSCH064) composed by 4 col-
umns of 13 electrodes and 1 column of 12, with 8 mm
interelectrode distance (IED) designed by LISiN at
Politecnico di Torino and manufactured by OT
Bioelettronica, Torino, Italy. The matrix was fixed on
the skin with double adhesive tape. The cavities corre-
sponding with the electrode were filled with 20 μl con-
ductive paste using a spatula to ensure proper
electrode–skin contact. sEMG signals were amplified
with an EMG-USB amplifier (LISiN - OT Bioelettronica,
Torino, Italy - bandwidth 10–750 Hz; adjustable gain
between 500 and 10,000; sampling frequency 2048 Hz;
16 bits A/D converter). Samples were visualised during
acquisition and stored on a personal computer OT-
Biolab software (OT Bioelettronica, Torino, Italy).
In order to measure the torque exerted by the upper
trapezius muscle, subjects were asked to sit on a custom
designed chair and hold both chair handles (Figure 1).
The handle on the right side was fixed to a load cell in
order to measure the force exerted during shoulder ele-
vation. Force signals were acquired and amplified (band-
width 0–80 Hz) using an MISOII amplifier (LISiN - OT
Bioelettronica, Torino, Italy). Subject feedback was pro-
vided by a bar of light-emitting diodes indicating the
percentage of the maximum voluntary contraction
(MVC) reached during each shoulder elevation. MTrP
pain pressure threshold (PPT) was assessed with a pres-
sure algometer (Wagner Instruments, Greenwich, CT,
USA) at an application rate of approximately 1 kg/s for
each MTrP. The algometer had a rubber tip with a 1-cm2
contact area.
Procedure
The day after enrolment and immediately prior to the
experimental procedure, patients with neck pain com-
pleted a Neck Disability Index (NDI) and a visual
analogue scale (VAS). The mean pain experienced in the
last week was reported. Pain-free subjects started the ex-
perimental procedures immediately.
Prior to each experimental session, the same operator
used a surgical pen to draw a standardised anatomical
coordinate system (ACS) on the right shoulder of sub-
jects while they were seated on the data acquisition
chair. The ACS consisted of a line between the spinal
process of the seventh vertebrae and the acromial angle
(X-axis), and a second line perpendicular to the first one
and passing through its midpoint (Y-axis). The centre ofthe electrode matrix was placed on the intersection be-
tween the axes with the matrix columns parallel to the
X-axis line so that the skin area covered by the matrix
was divided into four quadrants (first, second, third and
fourth).
To measure MVC, subjects were instructed to perform
a shoulder elevation task by pulling the chair’s handles
upwards. The MVC force level was determined as the
maximum of three isometric contractions. Two minutes
of rest were provided between the maximum exertions.
Each subject was given instructions and allowed to
practice for 5 min in order to learn to keep the force
level at 20% MVC using the feedback provided. Follow-
ing this, sEMG signals were acquired for 20 seconds at
20% MVC isometric contraction. After the electrode
matrix was removed, the expert physiotherapist per-
formed an examination of the upper trapezius muscle
using flat palpation techniques in order to locate the
MTrP according to the established diagnostic criteria
[31], and their location was marked on the skin using a
custom designed stamp (a 1-cm2 circle with a dot in the
centre). The dot in the centre was overlapped with the
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the ACS was measured with a ruler.
An operator blinded to the MTrP location performed
IZ visual analysis. The IZ was identified for each of the
five columns of the bi-dimensional electrode matrix by
means of visual analysis of the single differential sEMG
signals [32]. The criteria to detect their location on each
column were minimal amplitude and/or phase reversal
of signals [27,28]. Subsequently, IZ locations were de-
scribed according to ACS. To complete the IZ location
over the upper trapezius muscle IZs detected on matrix
columns were linked (linear interpolation) (Figure 2).
A PPT over the stamp was assessed for each MTrP.
The PPT was defined as the minimum pressure that
evokes local pain, and together with NDI (scale range, 0
to 50) and VAS (scale range, 0 to 100) provided detailed
descriptions of investigated population.
Statistical analysis
Data were tested for Gaussian distribution using
Shapiro-Wilk test. The mean and SD of NDI, VAS and
MTrPs PPTs were calculated in order to describe subject
clinical parameters. IZ and MTrP locations were de-
scribed in accordance to the four quadrants defined by
the ACS. The distance between the SP and the IZ (TrP-
IZ) was computed by tracing parallel to the X-axis,
reflecting the upper trapezius fibre direction [33] and
described as mean and SD. The TrP-IZ was measured
along the X-axis because the intention was to intercept
the IZs located in the same fibers that included theC7
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Figure 2 Electrode matrix placement. The red dot indicates an MTrP in
area covered by the electrode matrix. The IZ was typically located medially
and the IZ line. For each of the five columns of the matrix EMG signals are
was detected where EMG signals showed minimal amplitude and/or phase
vertebrae; SP, spot tenderness.MTrP (Figure 2). The correlations among variables
(NDI, PPT, VAS, X, Y, TrP-IZ) were examined using
Pearson correlation coefficients. The Student’s t-test (α =
0.05) was used to compare the values of X, Y and TrP-IZ
in active and latent MTrP, and finally to verify that TrP-
IZ was significantly different form zero. SPSS version 19
(SPSS Inc., IBM Company, New York, NY, USA) was
used to perform statistical analysis.
Results
All the considered variables showed a normal distribu-
tion (VAS: P=0.280, NDI: P=0.70, PPT: P=0.154, X:
P=0.595, Y: P=0.106, TrP-IZ: P=0.103). The enrolled
neck pain patients showed a mean VAS score of 37.3 ±
15.2 and a mean NDI score of 11 ± 5 out 50. The mean
PPT of the MTrPs was 2.6 ± 0.9 kg/cm2 (Table 1).
No significant correlations were found among vari-
ables except between X and TrP-IZ (P<0,01).
According to the ACS, 45 subjects showed an MTrP
medially located with respect to the Y-axis, and all the
MTrPs were located in the third quadrant except 3 that
were located in second quadrant (Figure 3). No statisti-
cally significant difference was found for X (P = 0.6) or
Y (P = 0.1) values between active and latent MTrPs.
The IZ was successfully detected in all subjects for
each of the matrix columns and was not larger than 8 mm
(i.e., the IED) (Figure 2). Typically, the IZ was located
medially with respect to the Y-axis and not further than
2.4 cm from the Y-axis (i.e., 3 IED) and in an area that ex-
tended from second to the third quadrant. It was10 mm 
1 
m
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5
the upper trapezius and the blue line shows the IZ location over the
to the Y-axis. TrP-IZ is the distance between SP in the MTrP region
reported and IZ locations indicated using a blue arrow. The IZ location
reversal. AC, acromial angle; C7, spinous process of the seventh
Table 1 Summarised results
Subject Group MTrPs VAS score NDI score PPT kg/cm2 X (mm) Y (mm) TrP-IZ (mm)
1 H L 2,9 −1 −1 10
2 NP A 51 21 1,3 −1 −1,5 2
3 NP L 21 8 2,1 −0,6 −1,5 10.5
4 NP A 30 7 3,9 −2,4 −1,6 4
5 H L 5,2 −1,2 0 0
6 NP A 49 18 2 −1,8 −1,3 14
7 H L 2,5 −1,9 −0,8 3
8 H L 3,7 −2 −0,6 16
9 H L 1,9 −1,7 −0,3 14.5
10 NP A 19 5 1,6 −2,5 −0,7 17.5
11 NP A 41 8 1,5 −2,3 −1,2 11
12 NP A 49 18 2,9 −1,3 −1,3 1
13 NP A 39 15 1,8 −1,6 −0,6 9
14 NP A 30 8 1 −2,7 −1,4 10
15 NP A 55 6 1,7 −1,4 −1,4 12
16 NP A 21 10 2,4 −2,2 −0,3 18
17 H L 2,4 −2,1 −0,5 19.5
18* NP A - - - −0,9 −2,1 -
19 H L 3,1 −0,1 −1,5 6.5
20 NP L 75 8 2,3 −1,8 −1,3 6
21 H L 2,9 −2,9 −1,4 9
22 H L 2,5 −1,6 −0,3 9
23 H L 2,8 −3,1 0 7
24 NP L 46 7 3,4 −1,7 −0,1 16.5
25 H L 2,7 −1,5 0 11
26 H L 1,8 −2,7 −0,6 16
27 H L 1,6 −1,1 −0,6 3
28 H L 2,7 −2 −0,4 14
29 H L 4,8 −2,7 −0,7 19
30 H L 2,6 −2,9 −1 20
31 H L 2,5 −0,7 −0,5 0.5
32 NP A 27 11 2,7 −2,2 0 10
33* H L - - - −1,4 −1,7 -
34 H L 3,2 −1,4 −0,6 10
35 H L 2,3 −1,4 −0,7 2.5
36 H L 1,9 −2,7 −0,5 12.5
37 H L 3,6 −2,1 0 13
38 H L 2,1 −2 0,1 8
39 NP A 20 4 3,2 −2,9 −0,7 17
40 H L 2,3 −2,6 0 14
41 H L 3,4 −1,5 −1,4 12
42 NP A 67 16 2 −2,3 0,5 11
43 NP A 39 16 1,7 −2,2 −0,6 15
44 NP L 47 13 2,7 −1,4 −1,5 10.5
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Table 1 Summarised results (Continued)
45 NP A 34 9 2,2 −1,9 −1,5 8
46 NP A 23 4 3,5 −0,5 0 1
47 NP L 33 13 4 −1,5 −0,4 1
48 NP A 34 11 3,8 −2,1 −0,6 16
49 NP L 25 9 2,1 −2,7 0,5 20
50 NP A 21 14 3 −1 −0,9 6
51* NP A - - - −2 −1,9 -
52* NP A - - - −1,8 −1,9 -
Mean±SD 37.3 ± 15.2 11 ± 5 2.6 ± 0.9 10.4 ± 5.8
Column two indicates patient group, H healthy group, NP neck pain group. Column three indicates MTrP status: A active MTrP, L latent MTrP. *Subjects who
showed an MTrP located outside the matrix were excluded from the analysis.
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quadrants (7 out of 48 subjects) (Figure 3).
The mean TrP-IZ was 10.4 ± 5.8 mm, with no statisti-
cally significant difference between active and latent
MTrPs (P = 0.6). TrP-IZ was significantly different from
zero (P<0.01). Figure 3 shows both MTrPs and IZ loca-
tions according to the ACS.
Discussion
The purpose of this work was to describe the location of
MTrPs and IZs in the upper trapezius muscle. It is un-
clear whether the locations of the MTrPs and the IZs
are closely related [2,16,23]. A study that investigates
both these locations in the same subjects has notFigure 3 Graphical representation of MTrPs and IZ location in the up
are represented as green circles and latent as white circles, and the colours
point density). B) IZ distribution, colour represents IZ density (dark blue are
different colours link IZs detected on the matrix columns. AC, acromial angpreviously been undertaken. Previous studies have
shown that the MTrP region includes active loci where
it is possible to identify low-amplitude electrical activity
(i.e., SEA), which was attributed to motor endplate dys-
function termed endplate noise. Additionally, high cor-
relation between MTrP site irritability and endplate
noise prevalence has been demonstrated by inserting an
EMG needle [34]. The endplate noise searching proced-
ure included the insertion of an intramuscular needle at
the MTrP region identified during palpation [10]. As
stated by the authors, this suggests an immediate prox-
imity between the MTrP and the IZ [8,10,16,18].
Results indicated that MTrPs were located in a well-
defined area of the upper trapezius with a PPT thatper trapezius according to the ACS in 48 subjects. A) Active MTrPs
indicate MTrP spatial densities (dark red spot indicates high trigger
a indicates high IZ density). C) Each IZ loction is represented by
le; C7, spinous process of the seventh cervical vertebrae.
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showing values similar to those reported in previous
studies [10,34,36].
In the current study, the investigated area was the in-
ferior part of upper trapezius and a portion of the upper
part of the mid trapezius where fibres were described to
be horizontally oriented [33]. This anatomical region is
where patients with neck pain typically report tender-
ness and where both active and latent MTrPs are fre-
quently observed [37]. The data describe an area for
MTrP location in upper trapezius that is similar to the
MTrP chart proposed by Simons and Travell, which also
matches the results of a recent study that used the same
ACS [38]. MTrPs in the upper trapezius appear to have
a stereotyped location, and clinicians could use our ACS
to guide their palpatory examinations.
No significant correlations were found among the
considered variables except between X and TrP-IZ, that
obvious considering how TrP-IZ was computed. Addi-
tionally, no significant differences were observed for ei-
ther X or Y values between active and latent MTrPs. A
similar location for active and latent MTrP would sup-
port, as described by Simons, a natural course for
myofascial pain that includes a subclinical stage in
which the MTrPs are not spontaneously painful (i.e., la-
tent) [5]. We screened 42 neck pain-free subjects with a
negative history for arm/shoulder complains, and just 16
were negative for TBs with SPs. The common presence
of TBs in pain-free subjects [37,39,40] and the similar
location for active and latent MTrPs seem to suggest
that TBs could be considered as a necessary precursor
to the development of MTrP. It is likely that stress fac-
tors (e.g., muscle overload or emotional distress) could
be involved in progression from latent to active [5]. This
was recently confirmed by Shah et al., who demon-
strated that active and latent MTrPs contain the same
biochemical substances [22] (bradykinin, substance P
and serotonin), and that their concentration is lower in
latent MTrPs compared with active MTrPs. In the
current study, SP compression failed to evoke com-
plaints (i.e., a negative PR criteria) in just 6 of 24 sub-
jects with neck pain, suggesting that MTrPs in the
upper trapezius frequently contribute to neck pain. The
presence of MTrPs should not be overlooked when
examining subjects with painful conditions; moreover,
high MTrP prevalence has been reported in several se-
lected patient populations [41-44].
The electrode matrix covered a 30.72 cm2 area (9.6 cm ×
3.2 cm), and the IZ can be approximately drawn on the
skin as a straight line that runs orthogonally to the
upper trapezius fibres and tends to curve medially to-
wards the spine in its caudal part. A similar distribution
for the IZ in upper trapezius was previously reported by
Saito el al. in three healthy subjects [29]. However, thisis the first time that IZ location was investigated in a
large group of subjects considering the area that extends
over the muscle surface. The same experimental setting
was applied a in previous study that did not focused on
the IZ morphology [26]. It should be noted that there
was limited variability for the IZ location in the upper
trapezius, and our results support the generally accepted
principle that muscles with parallel fibres contain IZs in
the midbelly [11].
Our findings confirm that the MTrPs in the upper tra-
pezius are located in proximity of the IZ but do not
overlap; rather, they are about 10 mm apart. In contrast
with previous investigations, we observed distinct loca-
tions for IZs and MTrPs, but it is important to note that
we investigated a different region of the upper trapezius,
from previous studies. Interestingly, MTrPs were not
equally distributed along the IZ and only affected spe-
cific groups fibres in the upper trapezius muscle.
The described close spatial relationship between IZ
and MTrPs can be potentially useful to guide treatments
targeting the IZ. As for example botulinum toxin injection
in various pain conditions including muscle spasticity, cer-
vical dystonia, headache and myofascial pain [24,45].
A few limitations need to be taken into account when
interpreting the results of this study.
We identified MTrP locations using SPs located on
TBs using palpation, similar to previous studies [10,34].
Although this method has been demonstrated to reliably
locate MTrPs in the upper trapezius, we are aware that
this only provides an approximation ranging from a few
millimetres to 1.5 centimetres [36]. Also our detection
methodology for the IZs and MTrPs gives bi-dimensional
locations on the skin, rather than a 3-dimensional loca-
tion. Finally, it is important to note that the electrode
array with 8-mm IED provides an approximation of about
4 mm when locating the IZ [26].
Conclusion
MTrP and IZ locations were described according to the
ACS in all enrolled subjects. MTrPs were located in
well-defined areas of the upper trapezius, showing a typ-
ical location with a mean TrP-IZ of 10 mm. MTrPs in
upper trapezius are proximally located to the IZ but not
overlapped. These results provide an interesting insight
for future research regarding the mechanism underlying
the MTrP iperalgesia. Moreover, the anatomical refer-
ence system proposed in this study may help clinicians
identify these areas.
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